Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1469 results

Pacemaker implantation after TAVI

21 Nov 2021 – From PCR London Valves 2021

Through this series of videos from PCR London Valves 2021, learn about the early outcomes of using the novel frame alignment technique during TAVI to improve pacemaker rates, see how cusp overlap projection reduces the burden of permanent pacemaker implantation after TAVR, appreciate the clinical utility of...

Pacemaker implantation after TAVI

TAVI in bicuspid aortic valves

21 Nov 2021 – From PCR London Valves 2021

Thanks to this series of videos from PCR London Valves 2021, analyze the results of self-expandable versus balloon-expandable transcatheter valves in bicuspid aortic anatomy, study the outcomes after TAVI in bicuspid aortic valve, and much more!

TAVI in bicuspid aortic valves

TAVI procedure planning and optimising patient outcomes

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 to evaluate whether TAVICT scans can replace invasive coronary angiography pre-TAVI, to appreciate how pre-operative computed tomography evaluation of aortic burden can predict acute kidney injury post-TAVR, and to appraise mortality in TAVI patients converted to...

TAVI procedure planning and optimising patient outcomes

Stroke prevention in TAVI

21 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, learn about the standard use of the cerebral embolism protection device in routine TAVR, find out more about the PROTEMBO C trial, and take a close look at the TriGUARD 3 device.

Stroke prevention in TAVI

Aortic valve disease: treatment and patient selection

21 Nov 2021 – From PCR London Valves 2021

Let's talk about severe asymptomatic aortic stenosis: what are the surgical standpoint and recent data from surgical literature? How to assess these patients? How to analyze CT? What do the newly published VHD Guidelines say? What is the place of MRI in these patients? So many questions...

Aortic valve disease: treatment and patient selection

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

21 Nov 2021 – From PCR London Valves 2021

Framed around a "live-in-a-box" case performed in Toulouse, the core of this session will be on procedural technique: how do you best perform a TAVI to get optimal outcomes in bicuspid anatomy? It will also focus on preprocedural planning, and in particular CT image analysis, and detail...

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

Aortic stenosis in the younger patient: procedural complications and lifetime management

21 Nov 2021 – From PCR London Valves 2021

Biological, surgical valves and TAVIs are being implanted in younger and younger patients. Since these procedures must be planned in the best possible way to minimize future complications, and because the lifetime management of these patients must be thought of, watch this session to get very useful...

Aortic stenosis in the younger patient: procedural complications and lifetime management

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

PCRonline @ TCT 2021

ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial

19 Oct 2021

In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.

Rafail Angelos Kotronias

Reviewer

Rafail Angelos Kotronias

Reviewer

Salvatore Brugaletta
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial

PCR TV: Valve selection considerations for the Heart Team

11 Oct 2021

Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...

PCR TV Valve selection considerations for the Heart Team

Cases on valvular disease

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...

Cases on valvular disease

Abstracts on TAVI

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...

Abstracts on TAVI

Best cases and research unveiled at AICT-Asia PCR 2021

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...

Best cases and research

Complications: calcified LM-LAD PCI, CHIP and TAVI

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them. 

Complications: calcified

TAVI in Asia-Pacific 2021: an update

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to be updated on the state of TAVI in 2021, especially in the Asia-Pacific Region, and learn more about the essential steps of TAVI procedure in a bicuspid valve.

TAVI in Asia-Pacific 2021: an update

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform